<div class="article">
	<h3>Business Brief -- IVAX Corp.:
   Miami Company Acquires
   Harris Pharmaceuticals Ltd.</h3>
	<div class="article-info">
		<ul>
			<li>Author: null</li>
			<li>Date: 12/31/90</li>
		</ul>
	</div>
	<p class="article-leader">IVAX Corp. said it completed the acquisition of Harris
Pharmaceuticals Ltd. for 6,250,000 common shares in a
transaction valued at $73.4 million.
   Harris makes and markets generic pharmaceuticals and has
facilities in London and Waterford, Ireland. Miami-based IVAX
is a holding company with interests in pharmaceuticals and
medical diagnostics. Three operating officers of Harris-Isaac
Kaye, Cyril Beck and Nigel Nortonwere appointed to IVAX's
board.</p>
	<div class="article-body"><p></p></div>
</div>
